Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Radiologically Isolated Syndrome (RIS) based on the 2023 diagnostic criteria — this is a condition where brain or spinal cord changes are seen on an MRI scan, but no symptoms have appeared yet
- People whose RIS was identified through a French Multiple Sclerosis registry called OFSEP (the French Multiple Sclerosis Observatory)
- People who have been diagnosed with Multiple Sclerosis (MS) according to the McDonald 2017 criteria, and whose neurological examination comes back normal
- People who are registered with the French social security system
Who may not be able to join:
- People who have movement, vision, or thinking/memory difficulties that are caused by something other than MS, where those difficulties could affect how well they perform the trial's tests
- People who have been diagnosed with progressive MS (a form of MS where symptoms gradually worsen over time, rather than coming and going)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33678601965
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparaison of digital biomarkers performance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.